From: Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome
Hormone (units) | Visit | n | Mean ± SD | Median |
---|---|---|---|---|
Free thyroxine (pmol/L) | Screening | 30 | 14.42 ± 2.53 | 14.65 |
Thyrotropin (mIU/L) | Screening | 30 | 2.38 ± 3.30 | 1.53 |
Estradiol (pmol/L) | Screening | 30 | 20.54 ± 25.59 | 9.18 |
6 month visit | 29 | 36.10 ± 104.95 | 9.18 | |
12 month visit | 26 | 25.95 ± 30.72 | 9.55 | |
LH (IU/L)* | Screening | 30 | 0.84 ± 1.04 | 0.45 |
6 month visit | 29 | 0.10 ± 0.02 | 0.10 | |
12 month visit | 28 | 0.11 ± 0.04 | 0.10 | |
FSH (IU/L) | Screening | 30 | 3.86 ± 5.42 | 1.95 |
6 month visit | 29 | 0.82 ± 0.78 | 0.50 | |
12 month visit | 29 | 1.13 ± 1.02 | 0.60 | |
Testosterone (nmol/L) | Screening | 30 | 0.53 ± 0.19 | 0.48 |
6 month visit | 29 | 0.56 ± 0.24 | 0.45 | |
12 month visit | 28 | 0.65 ± 0.27 | 0.66 |